The value in a trusted partnership
by Neal Salerno, President, Eurofins Lancaster Laboratories
Never in our lifetimes has the word partner had more significance than during this COVID-19 pandemic. From the beginning we partnered with our amazing staff to keep them safe by encouraging work flexibility and safety protocol adherence through social distancing and good hygiene. We partnered with clients by working closely to remain flexible as project prioritization changed and adapted schedules to help advance life-saving medical devices, drugs and vaccines to patients and medical staff in need. Across the globe we’ve partnered with all Eurofins sites, BioPharmaceutical companies, Governments, and non-profit organizations to help put an end to this crisis. Through these partnerships we have been able to keep our coworkers safe and maintain business continuity to support all the vital working happening in our industry.
For the BioPharm industry, our work truly is essential. Trusted for our decades of scientific expertise, vast range of capabilities, and driven work ethic, Eurofins BioPharma Product Testing stands together with clients in working non-stop to provide COVID-19 testing support wherever needed.
Behind the testing are our teams who have showed great flexibility and perseverance to help support clients’ COVID-19 therapeutic advancements. Many have changed or adjusted shifts with no overlap to maintain segregation, worked overtime and on weekends to meet clients’ TATs, offered expertise in exceptionally busy departments when needed, as well as work remotely where possible. We’ve always known that our people are our greatest asset, and they continually show their dedication during times like these. I’m extremely humbled and proud to work with such a great team.
With the race to deliver life-saving therapies and safe medical devices to patients and medical staff, Eurofins BioPharma Product Testing teams are providing clients with regulatory compliant data and expedited COVID-19 testing support for all drug modalities and parts of the supply chain, including Antivirals, Vaccines, mAbs, Antibodies, RNA, and Testing Kits, with expertise in:
- Raw Materials Testing
- Product Testing
- Viral Testing
- Microbiology
- Cell Banking
- Cell and Molecular Testing
- Stability and Release Testing and Method Development
- Medical Device Testing and Method Development
While the world’s focus is on the eradication of COVID-19, other diseases simply have not taken a time-out. Whether it is helping supply medicine for cancer, HIV, heart disease, or other health issues our employees continue to take pride and remain vigilant in helping clients battle these maladies and get essential medicines to the patients who need it.
Further, to ensure we meet the BioPharma industry’s high demand for expanded and expedited testing support of all drug modalities, we continually invest in our people, systems and facility as we’ve done for the last nearly 70 years. To accommodate clients’ ever- changing and increasing needs and flex our adaptability, every day we continue to:
- Purchase state-of-the-art instrumentation
- Hire experienced scientists and support staff
- Require employee training and encourage career development with new program offerings
- Invest in IT infrastructure and security to guard data integrity along with extensive capital and labor to increase technological controls (See Investing in Data Integrity)
- Improve Safety initiatives and training
- Expand and enhance facility and laboratory spaces, implementing Lean designs for improved efficiencies
From a business standpoint, we are fortunate to be in a good place to weather this storm and have such a phenomenal team and clients fighting the good fight.
More than ever before, we continue our mission and partnership with our clients to help make the world healthier and safer.
This pandemic will end. Life will return to normal. Until then, I hope you and your family stay healthy.